• Chris Froome at the recent Tirenno-Adriatico. (Getty)Source: Getty
The International Cycling Union (UCI) has reportedly advanced Chris Froome's defence for having excessive levels of the asthma medication Salbutamol in his system during the 2017 Vuelta a España to the next level.
By
Cycling Central

31 Mar 2018 - 10:56 AM 

French daily Le Monde reported on Friday that the UCI found Froome's and Team Sky's explanation unconvincing and have now referred the matter to its Independent Anti-Doping Tribunal.

Froome had twice the allowable amount of Salbutamol in his urine when tested on 7 September 2017 as he rode to his first Vuelta victory.

The UCI first had Froome's case assessed by its legal anti-doping services with the newspaper reporting it has now advanced to the next step of the process.

If the anti-doping tribunal then rules against the four-time Tour de France champion it will almost certainly land at the Court of Arbitration for Sport (CAS) on appeal.

That lengthy process means Froome remains on track to race at the Giro d'Italia, which starts in Jerusalem 4 May and perhaps the Tour itself in July.

Froome has continued to race since the news broke. He recently finished the Ruta del Sol (10th) and Tirreno-Adriatico (34th) and will fine-tune his Giro training at the Tour des Alpes.

No Tour for Froome if drug case unresolved?
Tour de France organisers will refuse to let Chris Froome race in this year's event if his salbutamol case has not been resolved, Press Association Sport understands.
Froome case to be a long one says Lappartient
The head of world cycling believes the complexity of Chris Froome's salbutamol case means a resolution is unlikely prior to the start of the Giro d'Italia on 4 May.
Elite sport: time to scrap the TUE system of banned medicines
Four-time Tour de France winner Chris Froome’s positive test for high levels of the asthma drug Salbutamol in September during the Vuelta a Espana race has prompted much debate on the rules surrounding medicines in sport.
Froome 'not ashamed' of using asthma inhaler
Chris Froome said overnight his inhaler use was "not something to be ashamed of" after his Sept 7 Vuelta a Espana urine test showed excess levels of Salbutamol, an asthma medication.
"I certainly haven't broken any rules" says Froome in interview
Chris Froome has spoken publicly in an interview for the first time since the announcement yesterday (AEDT) that his urine test results showed over twice the legal limit of Salbutamol after Stage 18 of the 2017 Vuelta a Espana.